Hormonal Effects on the Uterus and Endometrium
| Status: | Completed |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - 43 |
| Updated: | 4/5/2019 |
| Start Date: | April 21, 1995 |
| End Date: | July 27, 2015 |
Endometrial Mediators of Gonadal Steroid Action
Endometrium is the lining of the uterus. It is where the fertilized egg normally implants
during pregnancy.
This study was designed to better understand the way(s) that female sex hormones (estrogen
and progesterone) cause the uterus to grow and develop. It is known that these hormones are
necessary to prepare the uterus for pregnancy, but the way the hormones work is unknown.
Researchers would like to identify the genes that are affected by female sex hormones by
using a variety of tests (in situ hybridization, immunohistochemistry, and culture of human
endometrium).
Researchers will select women who have regular monthly menstrual cycles and study them for
two cycles;
1.The first cycle (PRE-BIOPSY CYCLE) will include daily measurements of the patient's
body temperature and progesterone measurements during the last 14 days (luteal phase) of
the menstrual cycle.
2. The second cycle (BIOPSY CYCLE) will include measurements of urinary luteinizing
hormone (LH) to determine the day of the LH surge. Luteinizing hormone is the hormone
that causes the ovary to release the developed egg. Ovarian ultrasounds will be
performed before the biopsy to determine development of the egg. Blood tests will be
taken on the day of the biopsy to have an overall idea of the hormones circulating in
the patient's blood. An endometrial biopsy will be taken at one of three possible times
to identify endometrial products under conditions of estrogen, estrogen/progesterone, or
steroid hormone withdrawal.
during pregnancy.
This study was designed to better understand the way(s) that female sex hormones (estrogen
and progesterone) cause the uterus to grow and develop. It is known that these hormones are
necessary to prepare the uterus for pregnancy, but the way the hormones work is unknown.
Researchers would like to identify the genes that are affected by female sex hormones by
using a variety of tests (in situ hybridization, immunohistochemistry, and culture of human
endometrium).
Researchers will select women who have regular monthly menstrual cycles and study them for
two cycles;
1.
body temperature and progesterone measurements during the last 14 days (luteal phase) of
the menstrual cycle.
2.
hormone (LH) to determine the day of the LH surge. Luteinizing hormone is the hormone
that causes the ovary to release the developed egg. Ovarian ultrasounds will be
performed before the biopsy to determine development of the egg. Blood tests will be
taken on the day of the biopsy to have an overall idea of the hormones circulating in
the patient's blood. An endometrial biopsy will be taken at one of three possible times
to identify endometrial products under conditions of estrogen, estrogen/progesterone, or
steroid hormone withdrawal.
Estrogen and progesterone induce characteristic and predictable morphological changes in the
endometrium that are required for successful implantation and pregnancy. The mechanism(s) by
which estrogen and progesterone exert these effects on the endometrium is not known. This is
a tissue collection protocol to obtain endometrium and/or menstrual effluent from normally
cycling women, women with endometriosis and women with infertility.
This tissue will be used for future studies intended to understand gonadal steroid action on
the endometrium We propose to identify peptides that are induced by endogenous estrogen and
progesterone using in situ hybridization, immunohistochemistry, microarray analysis and/or
culture of human endometrium obtained at hormonally different times of the cycle. Regularly
cycling women not at risk for pregnancy will be studied for two menstrual cycles. The first,
pre-biopsy cycle, will be characterized by daily basal body temperature measurements and a
luteal phase progesterone measurement. During the biopsy cycle, urinary LH measurements will
be performed to determine the day of the LH surge. Ovarian ultrasounds to assess follicular
development will be performed before biopsy. Blood will be obtained on the day of the biopsy
to characterize the hormonal mileau. An endometrial biopsy will be obtained either in the
early follicular phase (at a follicular diameter of less than 8 mm), the late follicular
phase (follicular diameter greater than 14 mm) or in the mid-(luteal phase day 6-8) or late
(luteal phase day 12 - 14) luteal phase, to allow identification of endometrial products
under conditions of estrogen, estrogen/progesterone and steroid withdrawal. Alternatively,
endometrial tissue may be obtained from normal women and those with endometriosis at the time
of menses using a cup-shaped intravaginal collecting device. Additionally, women with
infertility possibly related to endometrial dysfunction will be studied in the luteal phase.
endometrium that are required for successful implantation and pregnancy. The mechanism(s) by
which estrogen and progesterone exert these effects on the endometrium is not known. This is
a tissue collection protocol to obtain endometrium and/or menstrual effluent from normally
cycling women, women with endometriosis and women with infertility.
This tissue will be used for future studies intended to understand gonadal steroid action on
the endometrium We propose to identify peptides that are induced by endogenous estrogen and
progesterone using in situ hybridization, immunohistochemistry, microarray analysis and/or
culture of human endometrium obtained at hormonally different times of the cycle. Regularly
cycling women not at risk for pregnancy will be studied for two menstrual cycles. The first,
pre-biopsy cycle, will be characterized by daily basal body temperature measurements and a
luteal phase progesterone measurement. During the biopsy cycle, urinary LH measurements will
be performed to determine the day of the LH surge. Ovarian ultrasounds to assess follicular
development will be performed before biopsy. Blood will be obtained on the day of the biopsy
to characterize the hormonal mileau. An endometrial biopsy will be obtained either in the
early follicular phase (at a follicular diameter of less than 8 mm), the late follicular
phase (follicular diameter greater than 14 mm) or in the mid-(luteal phase day 6-8) or late
(luteal phase day 12 - 14) luteal phase, to allow identification of endometrial products
under conditions of estrogen, estrogen/progesterone and steroid withdrawal. Alternatively,
endometrial tissue may be obtained from normal women and those with endometriosis at the time
of menses using a cup-shaped intravaginal collecting device. Additionally, women with
infertility possibly related to endometrial dysfunction will be studied in the luteal phase.
- INCLUSION CRITERIA:
Healthy volunteers will be in excellent health.
Only women with regular menstrual cycles (every 26-35 days) using mechanical (condoms,
diaphragm) or sterilization methods of contraception will be included.
Only women with a negative pregnancy test, normal physical examination and laboratory
results, and a luteal phase progesterone value of greater than 4 ng/mL will be entered into
this study.
Women with endometriosis will be recruited from those with histologically-proven
endometriosis. Except for this diagnosis they will meet criteria for healthy volunteers as
stated above.
Women may participate in the study on more than one occasion, but biopsies may not be
performed in a "baseline" cycle.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Click here to add this to my saved trials
